Targeting CD52 does not affect murine neuron and microglia function
- 15 March 2020
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 871, 172923
- https://doi.org/10.1016/j.ejphar.2020.172923
Abstract
No abstract availableFunding Information
- Sanofi Genzyme
- German Research Council (DFG, CRC-TR-128)
This publication has 24 references indexed in Scilit:
- Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated CytolysisPLOS ONE, 2012
- In Vivo Imaging of Partially Reversible Th17 Cell-Induced Neuronal Dysfunction in the Course of EncephalomyelitisImmunity, 2010
- Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunityBrain, 2010
- Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalizationBrain, 2009
- Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disordersMultiple Sclerosis Journal, 2008
- Preparation of organotypic hippocampal slice cultures: interface methodNature Protocols, 2006
- Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in VivoScience, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Organotypic slice cultures: a technique has come of ageTrends in Neurosciences, 1997
- The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitisGlia, 1995